Cerebrovascular Complications of COVID-19 on Venovenous Extracorporeal Membrane Oxygenation

Written By CCRG

Zaaqoq, Akram M. MD, MPH; Griffee, Matthew J. MD; Kelly, Thu-Lan PhD; Fanning, Jonathon P. MD; Heinsar, Silver; Suen, Jacky Y. Ph3; Mariani, Silvia MD; Li Bassi, Gianluigi MD, PhD; Jacobs, Jeffrey P. MD; White, Nicole PhD; Fraser, John F. MD, PhD; Lorusso, Roberto MD, PhD; Peek, Giles J. MD; Cho, Sung-Min DO, MHS; COVID-19 Critical Care Consortium Critical Care Medicine DOI: 10.1097/CCM.0000000000005861

Objective: Evidence of cerebrovascular complications in COVID-19 requiring venovenous extracorporeal membrane oxygenation (ECMO) is limited. Our study aims to characterize the prevalence and risk factors of stroke secondary to COVID-19 in patients on venovenous ECMO.

CCRG
Previous

Morbid obesity’s impact on COVID-19 patients requiring venovenous extracorporeal membrane oxygenation
Next

Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era